These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 2896298)
1. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells. Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102 [TBL] [Abstract][Full Text] [Related]
3. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development. Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100 [TBL] [Abstract][Full Text] [Related]
5. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma). Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283 [TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
7. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324 [TBL] [Abstract][Full Text] [Related]
8. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system. Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616 [TBL] [Abstract][Full Text] [Related]
9. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes. Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337 [TBL] [Abstract][Full Text] [Related]
11. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608 [TBL] [Abstract][Full Text] [Related]
12. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651 [TBL] [Abstract][Full Text] [Related]
13. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2. Burdach S; Shatsky M; Wagenhorst B; Levitt L J Immunol; 1987 Jul; 139(2):452-8. PubMed ID: 3110272 [TBL] [Abstract][Full Text] [Related]
14. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies. Hanenberg H; Dilloo D; Laws HJ; Zessack N; Heyll A; Burdach S Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945 [TBL] [Abstract][Full Text] [Related]
15. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro. Iho S; Yamamoto T; Takahashi T; Yamamoto S J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958 [TBL] [Abstract][Full Text] [Related]
16. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. Le JM; Vilcek J J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
18. Differential effect of interleukin 10 on interleukin 12- and interleukin 2-mediated killer induction from blood mononuclear cells. Pai K; Yanagawa H; Takauchi E; Suzuki Y; Hanibuchi M; Parajuli P; Sone S Oncol Res; 1998; 10(6):295-300. PubMed ID: 9848100 [TBL] [Abstract][Full Text] [Related]
19. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha. Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. Yu CR; Kirken RA; Malabarba MG; Young HA; Ortaldo JR J Immunol; 1998 Jul; 161(1):218-27. PubMed ID: 9647227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]